APA (7th ed.) Citation

Liu, C., Hao, Y., Wang, L., Meng, F., Wen, F., & Zhong, D. (2021). Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte‐colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study. Wiley.

Chicago Style (17th ed.) Citation

Liu, Chang, Ying Hao, Lei Wang, Fanlu Meng, Fuyu Wen, and Diansheng Zhong. Safety and Efficacy of Administering Reduced Doses of Pegylated Recombinant Human Granulocyte‐colony Stimulating Factors in Patients Treated with Cisplatin and Etoposide for Small Cell Carcinoma: A Retrospective Study. Wiley, 2021.

MLA (8th ed.) Citation

Liu, Chang, et al. Safety and Efficacy of Administering Reduced Doses of Pegylated Recombinant Human Granulocyte‐colony Stimulating Factors in Patients Treated with Cisplatin and Etoposide for Small Cell Carcinoma: A Retrospective Study. Wiley, 2021.